Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T

Dennis Sandeman1, Maaz B J Syed2, Dorien M Kimenai3

  • 1Cardiology Department, NHS Fife, Kirkcaldy, UK.

Open Heart
|November 26, 2021
PubMed

Insights

Implementing an early rule-out pathway for acute coronary syndrome using high-sensitivity cardiac troponin T (hs-cTnT) <5 ng/L at presentation safely reduced hospital stays. This strategy allows for early discharge without compromising patient safety over one year.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarker Research

Background:

  • Acute coronary syndrome (ACS) diagnosis relies on clinical assessment and cardiac biomarkers.
  • High-sensitivity cardiac troponin (hs-cTn) assays improve early detection of myocardial injury.
  • Current protocols for ruling out ACS can lead to prolonged hospital stays.

Purpose of the Study:

  • To evaluate the safety and efficacy of an early rule-out pathway for suspected ACS.
  • To determine if a lower hs-cTnT threshold (<5 ng/L) facilitates safe early discharge.
  • To assess the impact on hospital duration of stay and 1-year all-cause mortality.

Main Methods:

  • Prospective single-centre cohort study comparing standard care with an early rule-out pathway.
  • Intervention group: rule-out if hs-cTnT <5 ng/L at presentation (symptoms ≥3h) or unchanged at 3h.
  • Standard care: rule-out if hs-cTnT <14 ng/L at presentation and 6-12h; compared duration of stay and 1-year mortality.

Main Results:

  • 10,315 patients included; 6642 (standard care) and 3673 (intervention).
  • Duration of stay significantly reduced from 534 min (IQR, 220-2279) to 390 min (IQR, 218-1910) (p<0.001).
  • 1-year all-cause death rates were similar: 10.9% (standard care) vs. 10.4% (intervention) (aOR 1.02, 95% CI 0.88-1.18).

Conclusions:

  • Implementing an early rule-out pathway using hs-cTnT <5 ng/L is effective in reducing hospital stay duration for suspected ACS.
  • This strategy demonstrates safety, with no significant increase in 1-year all-cause mortality.
  • The findings support the safe early discharge of low-risk patients with suspected ACS.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
392
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
113
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
41
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79